Categories AlphaGraphs, Earnings, Health Care
Biogen (BIIB) Earnings Infographic: Q2 profit, revenue drop but top estimates
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday said its second-quarter earnings and revenues decreased from last year. The results, however, came in above analysts’ forecast.
Net income attributable to the company was $448.5 million or $2.99 per share in the June quarter, down from last year’s profit of $1.54 billion or $9.59 per share. Adjusted earnings dropped to $5.68 per share from $9.85 per share but topped expectations.
Total revenues decreased 25% year-over-year to $2.78 billion during the three-month period. Analysts had predicted a bigger fall.
Read management/analysts’ comments on Biogen’s Q2 report
Shares of Biogen made strong gains early Thursday following the earnings announcement, after closing the previous session higher.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
